ESAB Corp (ESAB) stock fell about 2.7% over the past week, but Evercore ISI upgraded the stock to ‘In Line’ from ...

Evercore ISI analyst David Raso upgraded ESAB (ESAB) to In Line from Underperform with a price target of $120, down from $122. Along with Q4 ...

Evercore ISI analyst Durgesh Chopra maintained a Buy rating on Quanta Services (PWR – Research Report) on February 21 and set a price target of ...

Evercore shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.

Rich Ross, head of technical analysis at Evercore ISI, said that a breakout to an all-time high in the S&P 500 ( SP500 ), ( ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6, citing discounted valuation, a potential industry turnaround ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

Oshkosh (NYSE:OSK – Get Free Report) had its price target boosted by investment analysts at Evercore ISI from $122.00 to $137 ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

QuantumScape (NYSE:QS – Get Free Report) had its price target lowered by analysts at Evercore ISI from $10.00 to $8.00 in a ...

Evercore analysts predict a significant revenue boost for Apple Inc. (NASDAQ:AAPL) following the launch of the iPhone 16e and ...